Replies to post #130284 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

Sad in’it!

It does though reference the Anavex trial, but that's all.

[F1ash]

“Agonist of the intracellular sigma-1 chaperone protein. It is a mixed ligand for sigma-1 and muscarinic cholinergic receptors. It has shown anti amnesic and neuroprotective effects in preliminary studies and also has a clean Phase 1 clinical data”


Page 8 (370)

https://www.researchgate.net/profile/Abhinav_Anand23/publication/320161874_The_present_and_future_of_pharmacotherapy_of_Alzheimer%27s_disease_A_comprehensive_review/links/59f2917ba6fdcc1dc7bb1c28/The-present-and-future-of-pharmacotherapy-of-Alzheimers-disease-A-comprehensive-review.pdf


Think this one might be worth watching...?

MK-7622 / Phase 3. Muscarinic M4 receptor modulator